You are here

Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Children's Hospital
Oakland, California, 94609 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Gram-Positive Bacterial Infections
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
27 + weeks
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Serious, suspected or documented gram-positive infection

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
NCT00240747
Pfizer
Terminated
Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Gram-Positive Bacterial Infections, Cross Infection
NCT00081744
All Genders
Gram-Positive Bacterial Infections, Staphylococcus Infections, Vancomycin Resistance, Methicillin Resistance
NCT00079976
All Genders
Gram-Positive Bacterial Infections, Escherichia Coli Infections, Klebsiella Infections
NCT00167999
All Genders
15+
Years
Seoul,
Gram-Positive Bacterial Infections
NCT00167960
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now